Nitroxides, which are potent antioxidants, are proving to have broad utility in a number of disease processes and/or conditions that represent excessive oxidative stress. The fact that nitroxides exert activity over such a range of disease conditions speaks to the importance of free radical reactions in tissue. Likewise, it is becoming apparent that free radicals are important in normal molecular signaling pathways and related gene expression. Further, nitroxide application (lead compound is Tempol) in the diet of mice has been found to prevent obesity. A number of studies are underway to elucidate the mechanism of obesity prevention. Tempol administration to mice either in the diet or by gavage resulted in hundreds of altered urine metabolic products including numerous Tempol metabolites. Of particular interest were metabolites such as 2,8-dihydroxylquinoline and its glucuonide, which were elevated and metabolites such as panthothenic acid and isobutrylcarnitine, which were significantly attenuated compared to control. The presence of 2,8-dihydroxylquinoline is related to the gut microflora, which prompted a study to determine if Tempol treatment would alter the gut microflora profile in mice. Tempol administration was found to significantly change the gut microflora composition, in particular the Firmicute/Bacteroidete ratio consistent with a lean phenotype. The change in this ratio resulted from Tempol-medicated reduction of Lactobacillus and bile salt hydrolase activity leading to an accumulation of tauro-beta- muricholic acid (T-beta-MCA). Elevated T-beta-MCA inhibits farnesoid (FXR) signaling thus impacting lipid and glucose metabolism, which may underlie the anti-obesity properties of Tempol. Tempol has been shown to protect against free radical mediated DNA damage for ionizing radiation and hydrogen peroxide. Additional studies have demonstrated protection of DNA damage from the reverse transcriptase inhibitor NRTI and zidovudine. Lastly, tumor growth in mice results in systemic oxidative stress as evidenced by DNA damage in a variety of organs. Tumor-bearing animals on a Tempol-containing diet exhibited significantly less DNA damage to organs.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Investigator-Initiated Intramural Research Projects (ZIA)
Project #
1ZIASC006387-27
Application #
8938387
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
27
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Clinical Sciences
Department
Type
DUNS #
City
State
Country
Zip Code
Hu, L; Wang, Y; Cotrim, A P et al. (2017) Effect of Tempol on the prevention of irradiation-induced mucositis in miniature pigs. Oral Dis 23:801-808
Neil, Sarah; Huh, Jaebong; Baronas, Victoria et al. (2017) Oral administration of the nitroxide radical TEMPOL exhibits immunomodulatory and therapeutic properties in multiple sclerosis models. Brain Behav Immun 62:332-343
Kagiya, Go; Ogawa, Ryohei; Choudhuri, Rajani et al. (2015) Selective enhancement of hypoxic cell killing by tempol-regulated suicide gene expression. Oncol Rep 34:1065-73
Kim, Christine H J; Mitchell, James B; Bursill, Christina A et al. (2015) The nitroxide radical TEMPOL prevents obesity, hyperlipidaemia, elevation of inflammatory cytokines, and modulates atherosclerotic plaque composition in apoE-/- mice. Atherosclerosis 240:234-41
Wu, Haitao; Coble, Vincent; Vasalatiy, Olga et al. (2014) An efficient synthesis of 3-(N-piperidinemethyl)-2, 2, 5, 5-tetramethyl-1-oxy-3-pyrroline, a promising radioprotector for cancer radiotherapy. Tetrahedron Lett 55:5570-5571
Li, Fei; Jiang, Changtao; Krausz, Kristopher W et al. (2013) Microbiome remodelling leads to inhibition of intestinal farnesoid X receptor signalling and decreased obesity. Nat Commun 4:2384
Han, Gangwen; Bian, Li; Li, Fulun et al. (2013) Preventive and therapeutic effects of Smad7 on radiation-induced oral mucositis. Nat Med 19:421-8
Li, Fei; Pang, Xiaoyan; Krausz, Kristopher W et al. (2013) Stable isotope- and mass spectrometry-based metabolomics as tools in drug metabolism: a study expanding tempol pharmacology. J Proteome Res 12:1369-76
Li, Fei; Patterson, Andrew D; Krausz, Kristopher W et al. (2013) Metabolomics reveals that tumor xenografts induce liver dysfunction. Mol Cell Proteomics 12:2126-35
Hyodo, Fuminori; Davis, Ryan M; Hyodo, Emi et al. (2012) The relationship between tissue oxygenation and redox status using magnetic resonance imaging. Int J Oncol 41:2103-8

Showing the most recent 10 out of 23 publications